ONCOLOGY® Welcomes Six Tumor Chairs to Editorial Advisory Board
Retrieved on:
Wednesday, July 8, 2020
ONCOLOGY and CancerNetwork, a multispecialty platform focused on bringing practical, peer-reviewed content that can affect how oncologists, oncology nurses and other relevant health care professionals treat their patients, are excited to announce the addition of six tumor chairs to the editorial advisory board.
Key Points:
- ONCOLOGY and CancerNetwork, a multispecialty platform focused on bringing practical, peer-reviewed content that can affect how oncologists, oncology nurses and other relevant health care professionals treat their patients, are excited to announce the addition of six tumor chairs to the editorial advisory board.
- The ONCOLOGY editorial advisory board consists of some of the most prominent and credible medical professionals across the nation, said Mike Hennessy Jr., president and CEO of MJH Life Sciences, parent company of ONCOLOGY.
- In tandem with the 10 current members of the editorial advisory board, the tumor chairs will play a vital role in directing the content of ONCOLOGY.
- The ONCOLOGY tumor chairs are:
Breast cancer tumor chair: Sara A. Hurvitz, M.D., associate professor, medical oncologist, department of medicine, division of hematology and oncology, Jonsson Comprehensive Cancer Center, UCLA Medical Center.